Your browser doesn't support javascript.
loading
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
Pellegrino, Benedetta; Tommasi, Chiara; Serra, Olga; Gori, Stefania; Cretella, Elisabetta; Ambroggi, Massimo; Frassoldati, Antonio; Bisagni, Giancarlo; Casarini, Chiara; Bria, Emilio; Carbognin, Luisa; Fiorio, Elena; Mura, Antonella; Zamagni, Claudio; Gianni, Lorenzo; Zambelli, Alberto; Montemurro, Filippo; Tognetto, Michele; Todeschini, Renata; Missale, Gabriele; Campanini, Nicoletta; Silini, Enrico Maria; Maglietta, Giuseppe; Musolino, Antonino.
Afiliação
  • Pellegrino B; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Tommasi C; Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
  • Serra O; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Gori S; Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
  • Cretella E; Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
  • Ambroggi M; Medical Oncology Unit, Ospedale Sacro Cuore-Don Calabria-Negrar (VR), negrar, Italy.
  • Frassoldati A; Medical Oncology Unit, Ospedale di Bolzano, Bolzano, Italy.
  • Bisagni G; Medical Oncology, Hospital of Piacenza, Piacenza, Emilia-Romagna, Italy.
  • Casarini C; Specialist Medical Department, University Hospital Arcispedale Sant'Anna of Ferrara, Cona, Emilia-Romagna, Italy.
  • Bria E; Medical Oncology Unit, Azienda Unità Sanitaria Locale-IRCCS Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy.
  • Carbognin L; Medical Oncology Unit, Ospedale di Sassuolo, Sassuolo, Modena, Italy.
  • Fiorio E; Facolta di Medicina e Chirurgia, Universita Cattolica del Sacro Cuore, Roma, Lazio, Italy.
  • Mura A; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy.
  • Zamagni C; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy.
  • Gianni L; Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Zambelli A; Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Montemurro F; Department of Medical Oncology, Azienda USL Bologna, Bologna, Italy.
  • Tognetto M; Department of Oncology and Hematology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Emilia-Romagna, Italy.
  • Todeschini R; Oncology Department, Infermi Hospital, AUSL della Romagna, Rimini, Italy.
  • Missale G; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Lombardia, Italy.
  • Campanini N; Department of Oncology and Hematology, Candiolo Cancer Institute, Candiolo, Italy.
  • Silini EM; Gruppo Oncologico di Ricerca Clinica (GOIRC), Parma, Italy.
  • Maglietta G; Gruppo Oncologico di Ricerca Clinica (GOIRC), Parma, Italy.
  • Musolino A; Medicine and Surgery, Università degli Studi di Parma, Parma, Italy.
J Immunother Cancer ; 11(11)2023 11 28.
Article em En | MEDLINE | ID: mdl-38016718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália